Stryker (NYSE:SYK) said yesterday that CFO and veep William Jellison is retiring, and will be replaced by former medsurg & neurotechnology group CFO Glenn Boehnlein. The Kalamazoo, Mich.-based company said Jellison, who’s been with Styker for 3 years, will pursue positions on boards and devote more time to his family. Jellison will stay on through […]
Biomet
DJO Global closes Zimmer/Biomet buys
DJO Global said yesterday its subsidiary Encore Medical has closed on the purchase of Zimmer (NYSE:ZMH) and Biomet assets that the merging companies were unloading to satisfy U.S. anti-trust regulations. The purchase included Biomet Cobalt bone cement, Optivac cement mixing accessories, the SoftPac pouch and Discovery elbow system for the U.S. marketplace, DJO Global said. Financial details of […]
Zimmer & Biomet shift personnel after acquisition| Personnel Moves
Zimmer (NYSE:ZMH), who acquired Biomet in a deal that closed this month, announced a series of personnel shifts upon the closure of the merger. Zimmer CFO and senior veep James Crines has stepped down from his position to retire, effective August 3, to be replaced by former CFO and senior veep of BiometDaniel Florin, the company said. […]
Smith & Nephew to acquire Zimmer’s U.S. uni knee assets
Smith & Nephew (NYSE:SNN) said today that it agreed to acquire the U.S. unicompartmental High Flex knee assets from Zimmer (NYSE:ZMH), which is looking to mollify U.S. anti-trust regulators ahead of its $13.34 billion merger with Biomet. Warsaw, Ind.-based Zimmer last month said it had found buyers for the High Flex knee and Biomet’s Discovery elbow device and Biomet’s […]
Zimmer recalls some M/L Taper hip prostheses
Zimmer (NYSE:ZMH) is recalling some of its M/L Taper hip prosthesis with femoral stems and necks due to an issue concerning manufacturing residue on the devices, according to the FDA. The FDA labeled it a Class I recall, the most serious type of recall issued by the federal watchdog, indicating that “there is a reasonable probability that […]
Zimmer, Biomet find buyer for knee, elbow assets
Feds indict ex-Acclarent execs | The week in medtech M&A
Zimmer extends deadline for $13B Biomet deal
Biomet swings to Q3 black
Biomet today reported a return to fiscal 3rd-quarter profits, despite a foreign currency hit that pushed its top line down nearly 3%, in what’s likely its last financial release as an independent company.
MDT buys hearing aid maker Sophono | The week in medtech M&A
European regulators OK $13B Zimmer-Biomet deal
